Find information on thousands of medical conditions and prescription drugs.

Tazarotene

Tazorotene commonly called Tazorac is a prescription topical retinoid sold as a cream or gel. This medication is approved for treatment of Psoriasis, Acne and sun damaged skin (Photodamage). It is commonly sold in two concentrations: 0.05% and 0.1%. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Common side effects include worsening of acne, dry skin, itchiness, redness and in some cases extreme drying and cracking of skin. For most patients these side-effect are uncomfortable but mild and decrease markedly after the first 2-4 weeks of use.

For best results dermatologists recommend applying the cream or gel once daily before bedtime after washing the face with a mild soap.

Acne

When treating acne Tazarotene may be taken in conjunction with an oral antibiotic. To prevent resistance to the antibiotics a topical retinoid must be used. Results take at least 12 weeks to see optimum improvement. While Tazarotene's exact mechanism of action is unknown, it is thought that its effect on acne may be in part due to a reduction in sebum production.

Photodamage

Tazarotene has recently been approved for the treatment of photodamaged skin. Tazarotene has been shown in peer-reviewed double blinded studies to reduce: mottling and hyperpigmentation, sallowness, fine wrinkling and coarse wrinkling in sun damaged skin. Histological studies have shown that long term (greater than 1 year) use of Tazarotene is associated with a significant reduction in atypical melanocytes and keratocytes - cells considered to be precursors of skin cancer. Some studies have shown long term use of Tazarotene to be associated with increased collagen production and better organization of skin collagen bundles.

Read more at Wikipedia.org


[List your site here Free!]


Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study
From Journal of Drugs in Dermatology, 3/1/05

Histological Effects of Tazarotene 0.1% Cream vs. Vehicle on Photodamaged Skin: A 6-Month, Multicentre, Double-Blind, Randomized, Vehicle-Controlled Study in Patients with Photodamaged Facial Skin

Machtiner LA, Kaidbey K, Lim J, et al. British Journal of Dermatology. 2004;151:1245-1252.

Summary

The authors present a multicenter, double-blind, randomized, vehicle-controlled study to evaluate the histological effects of tazarotene cream in patients with photodamaged facial skin. Photodamaged facial skin was defined by the authors as mild fine wrinkling and mottled hyperpigmentation with at least one of these at a moderate level. Fifty patients were enrolled and randomized to receive either tazarotene or vehicle cream. Study medications were applied once daily for 24 weeks. All of the patients were Caucasian and 41 were female. The level of photodamage was approximately equal in both treatment groups. A 3-mm punch biopsy was taken at baseline and at week 24 from a representative area of photodamaged skin. These biopsies were evaluated by a single dermatopathologist who was blinded to the treatment group and as to whether a specimen was pre- or post-treatment. The primary outcome assessments were the distribution and severity of both keratinocytic and melanocytic atypia. Between-group comparisons showed a difference in the distribution or severity of both keratinocytic and melanocytic atypia in favor of the tazarotene-treated group, although this did not reach statistical significance. Of the secondary outcomes evaluated, there was a statistically significant difference in favor of the tazarotene group for increasing epidermal edema, number of granular cell layers, mean epidermal polarity scores, and epidermal thickness. Clinically, there was a statistically significant difference in favor of the tazarotene group in the overall assessment of photodamage.

Comment

This was a well-designed multicenter study that provided histological assessments of the effects of tazarotene cream as compared to vehicle. In assessing keratinocytic and melanocytic atypia, statistical significance was not reached though the between-group comparison did favor tazarotene. Statistical significance was reached in regard to epidermal polarity and thickness of the granular cell layer and epidermis, all of which suggest an improvement from the photodamage at baseline. It is also important to recognize that there was a statistically significant clinical improvement regarding the overall assessment of photodamage. A self-evaluation by the patient would have been of interest, though histological effects were the main objective of this study. In addition, all patients were Caucasian and of skin type I-IV. Thus these results cannot be generalized to people of different races and darker skin types.

Washington Whispers provides a summary and critical evaluation of the latest drug trials, studies, and reactions available to the medical community, as collated from a wealth of industry sources.

COPYRIGHT 2005 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2005 Gale Group

Return to Tazarotene
Home Contact Resources Exchange Links ebay